Replies to post #137169 on Biotech Values

[DewDiligence]

EXAS’ CEO, CFO, and CSO received hefty option awards on 2/27/12:

http://www.sec.gov/Archives/edgar/data/1124140/000118143112012992/xslF345X03/rrd336499.xml
http://www.sec.gov/Archives/edgar/data/1124140/000118143112012990/xslF345X03/rrd336511.xml
http://www.sec.gov/Archives/edgar/data/1124140/000118143112012991/xslF345X03/rrd336514.xml

I’m not necessarily opposed to these awards, but they seem somewhat generous for a company that isn’t (yet) profitable.